Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 9K24DA040489 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to learn about ways to better support people living with HIV with their HIV treatment and cope with mental health challenges and/or substance use concerns.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cognitive Behavioral Therapy (CBT) for Syndemic and Adherence Factors Group | Experimental | Participants in this group will receive the CBT for Syndemics and Adherence Factors intervention for a total of 14 sessions over 4 months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CBT for Syndemics and Adherence Factors | Behavioral | Each hour-long session is conducted via zoom or in person with a study clinician. Sessions focus on HIV medication adherence, coping with life stressors, and managing other challenging situations (e.g., possible traumatic experiences, drug and alcohol use and sexual behavior) that may affect mental or HIV-related health. |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of participants who completes the follow up assessment | Feasibility will be reported as the percentage of participants who completes the study follow up assessment. | 8 months |
| Measure | Description | Time Frame |
|---|---|---|
| ART Medication Adherence | Antiretroviral Therapy (ART) adherence will be reported as the percentage of participants who reports taking > 80% of their ART from baseline up to follow up visit. | Up to 8 months |
| Percentage of participants with undetectable viral load |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Three distinct groups will be recruited: 1) Men who have sex with men who use stimulants, 2) transgender women, 3) emerging adults (ages 18-26 years).
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Steven A Safren, PhD | University of Miami | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D055118 | Medication Adherence |
| D000092862 | Psychological Well-Being |
| ID | Term |
|---|---|
| D010349 | Patient Compliance |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D000076603 | Syndemic |
| ID | Term |
|---|---|
| D015981 | Epidemiologic Factors |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
As assessed via serum blood samples. |
| Up to 8 months |
| Percentage of participants with improvement in syndemic, behavioral health outcomes | Participants with a 2-point reduction in their Diagnostic Interview for Anxiety, Mood and Obsessive Compulsive Disorder (OCD) Related Neuropsychiatric Disorders (DIAMOND) scores from baseline will be reported as having improvement in behavioral health outcome. DIAMOND has a total score ranging from 1-7 with the higher score indicating greater severity. | Up to 8 months |
| D001519 | Behavior |
| D010549 | Personal Satisfaction |